Comment
. 2006 Jan 5;354(1):94-6; author reply 94-6.
doi: 10.1056/NEJMc052759.
Drotrecogin alfa (activated) in severe sepsis
- PMID: 16394311
- DOI: 10.1056/NEJMc052759
Item in Clipboard
Comment
Drotrecogin alfa (activated) in severe sepsis
N Engl J Med.
.
No abstract available
Comment on
-
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.N Engl J Med. 2005 Sep 29;353(13):1332-41. doi: 10.1056/NEJMoa050935. N Engl J Med. 2005. PMID: 16192478 Clinical Trial.
Similar articles
-
Drotrecogin alfa (activated) in severe sepsis.N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6. N Engl J Med. 2006. PMID: 16395834 No abstract available.
-
Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death.Crit Care. 2006;10(6):427. doi: 10.1186/cc5117. Crit Care. 2006. PMID: 17214908 Free PMC article. No abstract available.
-
Drotrecogin alfa (activated) in severe sepsis.N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6. N Engl J Med. 2006. PMID: 16395833 No abstract available.
-
[Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice].Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:53-64. Ann Fr Anesth Reanim. 2003. PMID: 15359946 Review. French. No abstract available.
-
Advances in treating patients with severe sepsis. Role of drotrecogin alfa (activated).Crit Care Nurse. 2003 Jun;23(3):16-29; quiz 67-8. Crit Care Nurse. 2003. PMID: 12830777 Review. No abstract available.
Cited by
-
Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis.BMC Anesthesiol. 2007 Jun 25;7:5. doi: 10.1186/1471-2253-7-5. BMC Anesthesiol. 2007. PMID: 17592639 Free PMC article.
-
An update on activated protein C (xigris) in the management of sepsis.P T. 2010 Sep;35(9):504-29. P T. 2010. PMID: 20975809 Free PMC article. No abstract available.
-
Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death.Crit Care. 2006;10(6):316. doi: 10.1186/cc5071. Crit Care. 2006. PMID: 17094794 Free PMC article. No abstract available.
-
Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?Crit Care. 2006;10(3):145. doi: 10.1186/cc4947. Epub 2006 Jun 2. Crit Care. 2006. PMID: 16762040 Free PMC article. Review.
-
Current role of activated protein C therapy for severe sepsis and septic shock.Curr Infect Dis Rep. 2008 Sep;10(5):368-76. doi: 10.1007/s11908-008-0060-5. Curr Infect Dis Rep. 2008. PMID: 18687200
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
